1415319-39-9

Upstream product

• 108-77-0 1,3,5-trichloro-2,4,6-triazine 
• 88-05-1 2,4,6-trimethylaniline 

Downstream Products

• 1415319-96-8 4-((4-((2-((4,6-bis(mesitylamino)-1,3,5-triazin-2-yl)amino)ethyl)amino)-6-(mesitylamino)-1,3,5-triazin-2-yl)amino)benzonitrile 
• 1415319-97-9 4-((4-((3-((4,6-bis(mesitylamino)-1,3,5-triazin-2-yl)amino)propyl)amino)-6-(mesitylamino)-1,3,5-triazin-2-yl)amino)benzonitrile 
• 1415319-56-0 N²,N^2'-(butane-1,4-diyl)bis(N⁴,N⁶-dimesityl-1,3,5-triazine-2,4,6-triamine) 
• 1415319-57-1 N²,N^2'-(pentane-1,5-diyl)bis(N⁴,N⁶-dimesityl-1,3,5-triazine-2,4,6-triamine) 
• 1415319-54-8 N²,N^2'-(ethane-1,2-diyl)bis(N⁴,N⁶-dimesityl-1,3,5-triazine-2,4,6-triamine) 
• 1434129-19-7 N₂,N₄-dimesityl-1,3,5-triazine-2,4,6-triamine 
• 1415319-55-9 N²,N^2'-(propane-1,3-diyl)bis(N⁴,N⁶-dimesityl-1,3,5-triazine-2,4,6-triamine) 

Relevant academic research and scientific papers

DISUBSTITUTED TRIAZINE DIMERS FOR TREATMENT AND/OR PREVENTION OF INFECTIOUS DISEASES

The present invention relates to novel compounds (I) containing two disubstituted triazine rings covalently linked by an organic linker, thereby creating dimers. These compounds show activity against the causative infective agents of infectious diseases s

From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds

The presence of a structural recognition motif for the nucleoside P2 transporter in a library of pyrimidine and triazine non-nucleoside HIV-1 reverse transcriptase inhibitors, prompted for the evaluation of antitrypanosomal activity. It was demonstrated that the structure-activity relationship for anti-HIV and antitrypanosomal activity was different. Optimization in the diaryl triazine series led to 6-(mesityloxy)-N2-phenyl-1,3,5-triazine-2,4-diamine (69), a compound with potent in vitro and moderate in vivo antitrypanosomal activity.

DISUBSTITUTED TRIAZINE DIMERS FOR TREATMENT AND/OR PREVENTION OF INFECTIOUS DISEASES

The present invention relates to novel compounds (I) containing two disubstituted triazine rings covalently linked by an organic linker, thereby creating dimers. These compounds show activity against the causative infective agents of infectious diseases s